<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:dn="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85124278291</prism:url><dc:identifier>SCOPUS_ID:85124278291</dc:identifier><eid>2-s2.0-85124278291</eid><pubmed-id>35085623</pubmed-id><pii>S0169409X22000060</pii><prism:doi>10.1016/j.addr.2022.114116</prism:doi><article-number>114116</article-number><dc:title>Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><citedby-count>3</citedby-count><prism:publicationName>Advanced Drug Delivery Reviews</prism:publicationName><dc:publisher>Elsevier B.V.</dc:publisher><source-id>19409</source-id><prism:issn>18728294 0169409X</prism:issn><prism:volume>182</prism:volume><prism:coverDate>2022-03-01</prism:coverDate><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag><dc:creator><author seq="1" auid="57445233400"><ce:initials>D.</ce:initials><ce:indexed-name>Aldarondo D.</ce:indexed-name><ce:surname>Aldarondo</ce:surname><ce:given-name>Dasia</ce:given-name><preferred-name><ce:initials>D.</ce:initials><ce:indexed-name>Aldarondo D.</ce:indexed-name><ce:surname>Aldarondo</ce:surname><ce:given-name>Dasia</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57445233400</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author></dc:creator><dc:description><abstract xmlns="" original="y" xml:lang="eng"><publishercopyright>Â© 2022</publishercopyright><ce:para>Due to the increasing population of individuals with cardiovascular diseases and related comorbidities, there is an increasing need for development of synergistic therapeutics. Monocytes are implicated in a broad spectrum of diseases and can serve as a focal point for therapeutic targeting. This review discusses the role of monocytes in cardiovascular diseases and highlights trends in monocyte targets nanoparticles in three cardiovascular-related diseases: Diabetes, Atherosclerosis, and HIV. Finally, the review offers perspectives on how to develop nanoparticle monocyte targeting strategies that can be beneficial for treating co-morbidities.</ce:para></abstract></dc:description><link href="https://api.elsevier.com/content/abstract/scopus_id/85124278291" rel="self"/><link href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85124278291&amp;origin=inward" rel="scopus"/><link href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85124278291&amp;origin=inward" rel="scopus-citedby"/></coredata><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"><affilname>Carnegie Mellon University</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><authors><author seq="1" auid="57445233400"><ce:initials>D.</ce:initials><ce:indexed-name>Aldarondo D.</ce:indexed-name><ce:surname>Aldarondo</ce:surname><ce:given-name>Dasia</ce:given-name><preferred-name><ce:initials>D.</ce:initials><ce:indexed-name>Aldarondo D.</ce:indexed-name><ce:surname>Aldarondo</ce:surname><ce:given-name>Dasia</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57445233400</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author><author seq="2" auid="56014391900"><ce:initials>E.</ce:initials><ce:indexed-name>Wayne E.</ce:indexed-name><ce:surname>Wayne</ce:surname><ce:given-name>Elizabeth</ce:given-name><preferred-name><ce:initials>E.</ce:initials><ce:indexed-name>Wayne E.</ce:indexed-name><ce:surname>Wayne</ce:surname><ce:given-name>Elizabeth</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/56014391900</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author></authors></abstracts-retrieval-response>